Aminocaproic Acid

氨基己酸

Report date: 2023/02/27 09:46:56
NME

Base Information

Drug NameAminocaproic Acid
Drug Alias Nameε-アミノカプロン酸6-氨基己酸Acidum aminocaproicum胺基己酸Epsilon aminocaproic acid +[15] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPlasminogen activators inhibitors
TargetsPlasminogen activators
Therapy Area/IndicationsHemorrhageRosaceaTransfusion Reaction +[10] 
Global Approved IndicationsHemorrhage
Approved Indications in ChinaHemorrhage
Original Approved Country/TerritoryUnited States
Original Approved Date1964/06/03
Country/TerritoryUnited StatesMexicoMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesClover Pharmaceuticals Corp
China Registration ClassN/A

Develop Information

Active CompaniesChildren'S National Research InstituteHikmaHunan Hongchun Pharmaceutical Co Ltd
Inactive CompaniesUniversidad Autonoma de Nuevo LeonUT Health San AntonioUniversity Of California San Diego +[5] 
Active IndicationsHemorrhageCraniosynostoses
Inactive IndicationsRosaceaTransfusion ReactionThrombocytopenia +[8] 

Other Information

ATC CodeB02AA01
Related LinksWikipediaDrugBankKEGG